MYCN and neoplasm: miR-125b inhibits neuroblastoma cell proliferation and promotes cell differentiation in in vitro models [49], [50], so that down-regulation of this miRNA could potentially be contributing towards the more aggressive phenotype of the TH-MYCN/p53-ERTAM tumor phenotype.